# Enhanced Facial Rejuvenation: Biostimulatory Effects of Hylan Gel Dermal Filler DX on Collagen Synthesis and Tissue Regeneration

**Authors:** Rodolfo M. Ortiz-Flores, Alejandro Escamilla-Sanchez, Borja Cidoncha-Morcillo, Luis Mastronardi, Silvia Fontenete, Regina Garcia-Delgado

PMC · DOI: 10.1007/s00266-025-05245-5 · Aesthetic Plastic Surgery · 2025-10-13

## TL;DR

This study explores a new dermal filler that boosts collagen and tissue regeneration for facial rejuvenation.

## Contribution

The paper introduces Hylan Gel Dermal Filler DX, a novel HA-DX filler with enhanced regenerative and anti-inflammatory properties.

## Key findings

- Hylan Gel Dermal Filler DX stimulated collagen and elastin production more effectively than other fillers.
- The filler showed improved fibroblast migration and wound healing in vitro.
- It modulated cytokines to reduce inflammation and support tissue regeneration.

## Abstract

Facial rejuvenation involves addressing the breakdown of collagen and elastin that occurs with aging. Hyaluronic acid (HA)-based dermal fillers have become a key non-invasive treatment, known for their volumizing effects and potential regenerative benefits. This study characterizes the physicochemical and rheological properties of Hylan Gel Dermal Filler DX, a novel filler combining HA and dextranomer microspheres, and evaluates its capacity to enhance extracellular matrix regeneration.

Rheological analysis was conducted to determine viscoelastic properties, including storage modulus (G'), loss modulus (G''), and tan delta across frequencies (0.1–10 Hz). In vitro experiments with normal human dermal fibroblasts (NHDFs) and monocytes (J774A.1) assessed the effects of Hylan Gel Dermal Filler DX (HA + DX), Genefill Soft Fill (HA), HarmonyCa® (HA+CaHa), Radiesse® (CaHa), and Sculptra® (PLLA). Hydration and wound healing assays were also performed. Biomarker analysis focused on collagen types I, III, IV, VI, elastin, and cytokines (TGF-β1, IL-1β, IL-6, IL-10, TNFα).

Rheologically, HA + DX displayed a balanced elastic and viscous profile, supporting its structural integrity and adaptability in dynamic facial areas. HA + DX demonstrated high stimulation of collagen types I, III, IV, VI, and elastin production, with enhanced fibroblast migration and wound healing at 72 hours compared to other fillers. HA + DX also modulated cytokines, increasing TGF-β1 and IL-10 while reducing TNFα and IL-1β, suggesting anti-inflammatory and regenerative properties.

HA + DX exhibited considerable benefits in collagen stimulation, wound healing, and cytokine modulation. Its favorable rheological characteristics and regenerative potential make it a promising option for facial rejuvenation and tissue regeneration.

This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266

The online version contains supplementary material available at 10.1007/s00266-025-05245-5.

## Linked entities

- **Proteins:** COL3A1 (collagen type III alpha 1 chain), LIMK1 (LIM domain kinase 1), TGFB1 (transforming growth factor beta 1), IL1B (interleukin 1 beta), IL6 (interleukin 6), IL10 (interleukin 10), TNF (tumor necrosis factor)
- **Chemicals:** PLLA (PubChem CID 107689)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** inflammatory (MESH:D007249)
- **Chemicals:** HA (MESH:D006820), Radiesse (MESH:D017886), Hylan (MESH:C049816), Dermal Filler DX (-), dextranomer (MESH:C013471), Sculptra (MESH:C482305)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** NHDFs — Macaca fascicularis (Crab-eating macaque), Finite cell line (CVCL_LC41), J774A.1 — Mus musculus (Mouse), Mouse reticulum cell sarcoma, Cancer cell line (CVCL_0358)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12957018/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12957018/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12957018/full.md

---
Source: https://tomesphere.com/paper/PMC12957018